Treatment of infantile primary pulmonary hypertension by intravenous infusion of lipo-prostaglandin I2 analog.
We used a new vasodilator, TTC-909 (a prostaglandin I2 analog incorporated in lipid microspheres), which produced marked reduction in the pulmonary arterial pressure and resistance in an infant with primary pulmonary hypertension.
Takigiku
K
K
Department of Pediatrics, Yokohama City University School of Medicine, Japan.
Shibata
T
T
Yasui
K
K
Iwamoto
M
M
Sagawa
K
K
Yamaoka
K
K
Tsuda
N
N
D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007223:Infant; D007262:Infusions, Intravenous; D014665:Vasodilator Agents / Q000627:therapeutic use*
C068518:TTC 909; D014665:Vasodilator Agents; D011464:Epoprostenol